Organization, function, and therapeutic targeting of the morbillivirus RNA-dependent RNA polymerase complex

Viruses

Volumn 8, Issue 9, 2016, Pages

  Sourimant, Julien ^a   Plemper, Richard K ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Antiviral drug; Measles virus; Morbillivirus; Polymerase inhibitor; Viral polymerase

Indexed keywords

1 (2,3 DIHYDRO 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (2 FLUOROPHENYL)UREA; ANTIVIRUS AGENT; AZ 27; DIHYDROLIPOAMIDE DEHYDROGENASE; ERDRP 0519; GLYCINE DEHYDROGENASE (DECARBOXYLATING); MEASLES VACCINE; MESSENGER RNA; NUCLEOCAPSID PROTEIN; RIBAVIRIN; RNA DIRECTED RNA POLYMERASE; RNA DIRECTED RNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; VACCINE; ENZYME INHIBITOR;

DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; ENZYME INHIBITION; ENZYME STRUCTURE; HUMAN; MEASLES; MORTALITY; NONHUMAN; PHOSPHORYLATION; REVIEW; STRUCTURE ACTIVITY RELATION; VACCINATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ANIMAL; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; MORBILLIVIRUS;

ANIMALS; ANTIVIRAL AGENTS; ENZYME INHIBITORS; HUMANS; MORBILLIVIRUS; RNA REPLICASE;

EID: 84987788957     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8090251     Document Type: Review

References (143)

1. Afonso, C.L.; Amarasinghe, G.K.; Banyai, K.; Bao, Y.; Basler, C.F.; Bavari, S.; Bejerman, N.; Blasdell, K.R.; Briand, F.X.; Briese, T.; et al. Taxonomy of the order Mononegavirales: Update 2016. Arch. Virol. 2016, 161, 2351–2360. [CrossRef] [PubMed]
2. Larkin, M.A.; Blackshields, G.; Brown, N.P.; Chenna, R.; McGettigan, P.A.; McWilliam, H.; Valentin, F.; Wallace, I.M.; Wilm, A.; Lopez, R.; et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23, 2947–2948. [CrossRef] [PubMed]
3. Goujon, M.; McWilliam, H.; Li, W.; Valentin, F.; Squizzato, S.; Paern, J.; Lopez, R. A new bioinformatics analysis tools framework at EMBL–EBI. Nucleic Acids Res. 2010, 38 (Suppl. 2), W695–W699. [CrossRef] [PubMed]
4. McWilliam, H.; Li, W.; Uludag, M.; Squizzato, S.; Park, Y.M.; Buso, N.; Cowley, A.P.; Lopez, R. Analysis Tool Web Services from the EMBL-EBI. Nucleic Acids Res. 2013, 41, W597–W600. [CrossRef] [PubMed]
5. Felsenstein, J. Mathematics vs. Evolution: Mathematical Evolutionary Theory. Science 1989, 246, 941–942. [CrossRef] [PubMed]
6. Dereeper, A.; Guignon, V.; Blanc, G.; Audic, S.; Buffet, S.; Chevenet, F.; Dufayard, J.F.; Guindon, S.; Lefort, V.; Lescot, M.; et al. Phylogeny.fr: Robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 2008, 36, W465–W469. [CrossRef] [PubMed]
7. Kelly, H.A.; Riddell, M.A.; Andrews, R.M. Measles transmission in healthcare settings in Australia. Med. J. Aust. 2002, 176, 50–51. [PubMed]
8. Perry, R.T.; Halsey, N.A. The clinical significance of measles: A review. J. Infect. Dis. 2004, 189 (Suppl. 1), S4–S16. [CrossRef] [PubMed]
9. Hospital-associated measles outbreak—Pennsylvania, March–April 2009. MMWR Morb. Mortal. Wkly. Rep. 2012, 61, 30–32.
10. Anderson, R.M.; May, R.M. Age-related changes in the rate of disease transmission: Implications for the design of vaccination programmes. J. Hyg. (Lond) 1985, 94, 365–436. [CrossRef] [PubMed]
11. WHO. Global control and regional elimination of measles, 2000–2012. Wkly. Epidemiol. Rec. 2014, 89, 45–52.
12. Larson, H.J.; Cooper, L.Z.; Eskola, J.; Katz, S.L.; Ratzan, S. Addressing the vaccine confidence gap. Lancet 2011, 378, 526–535. [CrossRef]
13. Saint-Victor, D.S.; Omer, S.B. Vaccine refusal and the endgame: Walking the last mile first. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 2013, 368, 20120148. [CrossRef] [PubMed]
14. Measles—United States, 2011. MMWR Morb. Mortal. Wkly. Rep. 2012, 61, 253–257.
15. Plemper, R.K.; Snyder, J.P. Measles control—Can measles virus inhibitors make a difference? Curr. Opin. Investig. Drugs 2009, 10, 811–820. [PubMed]
16. Plemper, R.K.; Hammond, A.L. Synergizing vaccinations with therapeutics for measles eradication. Expert Opin. Drug Discov. 2014, 9, 201–214. [CrossRef] [PubMed]
17. Cox, R.; Plemper, R.K. The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics. Front. Microbiol. 2015, 6, 459. [CrossRef] [PubMed]
18. Krumm, S.A.; Yan, D.; Hovingh, E.S.; Evers, T.J.; Enkirch, T.; Reddy, G.P.; Sun, A.; Saindane, M.T.; Arrendale, R.F.; Painter, G.; et al. An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model. Sci. Transl. Med. 2014, 6, 232ra52. [CrossRef] [PubMed]
19. Castaneda, S.J.; Wong, T.C. Leader sequence distinguishes between translatable and encapsidated measles virus RNAs. J. Virol. 1990, 64, 222–230. [PubMed]
20. Horikami, S.M.; Moyer, S.A. Synthesis of leader RNA and editing of the P mRNA during transcription by purified measles virus. J. Virol. 1991, 65, 5342–5347. [PubMed]
21. Sidhu, M.S.; Chan, J.; Kaelin, K.; Spielhofer, P.; Radecke, F.; Schneider, H.; Masurekar, M.; Dowling, P.C.; Billeter, M.A.; Udem, S.A. Rescue of synthetic measles virus minireplicons: Measles genomic termini direct efficient expression and propagation of a reporter gene. Virology 1995, 208, 800–807. [CrossRef] [PubMed]
22. Anderson, D.E.; Castan, A.; Bisaillon, M.; von Messling, V. Elements in the canine distemper virus M 30 UTR contribute to control of replication efficiency and virulence. PLoS ONE 2012, 7, e31561. [CrossRef] [PubMed]
23. Calain, P.; Roux, L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J. Virol. 1993, 67, 4822–4830. [PubMed]
24. Radecke, F.; Spielhofer, P.; Schneider, H.; Kaelin, K.; Huber, M.; Dotsch, C.; Christiansen, G.; Billeter, M.A. Rescue of measles viruses from cloned DNA. Embo J. 1995, 14, 5773–5784. [PubMed]
25. Plumet, S.; Duprex, W.P.; Gerlier, D. Dynamics of viral RNA synthesis during measles virus infection. J. Virol. 2005, 79, 6900–6908. [CrossRef] [PubMed]
26. Lamb, R.A.; Parks, G.D. Paramyxoviridae: The viruses and their replication. In Fields Virology, 5th ed.; Knipe, D.M., Howley, P.M., Eds.;Wolters Kluwer/LippincottWilliams &Wilkins: Philadelphia PA, USA, 2007; Volume 1, pp. 1449–1469.
27. Cattaneo, R.; Rebmann, G.; Schmid, A.; Baczko, K.; ter Meulen, V.; Billeter, M.A. Altered transcription of a defective measles virus genome derived from a diseased human brain. Embo J. 1987, 6, 681–688. [PubMed]
28. Smallwood, S.; Moyer, S.A. The L polymerase protein of parainfluenza virus 3 forms an oligomer and can interact with the heterologous Sendai virus L, P and C proteins. Virology 2004, 318, 439–450. [CrossRef] [PubMed]
29. Dochow, M.; Krumm, S.A.; Crowe, J.E., Jr.; Moore, M.L.; Plemper, R.K. Independent structural domains in the paramyxovirus polymerase protein. J. Biol. Chem. 2012, 287, 6878–6891. [CrossRef] [PubMed]
30. Diallo, A.; Barrett, T.; Barbron, M.; Meyer, G.; Lefevre, P.C. Cloning of the nucleocapsid protein gene of peste-des-petits-ruminants virus: Relationship to other morbilliviruses. J. Gen. Virol. 1994, 75 Pt 1, 233–237. [CrossRef] [PubMed]
31. Woo, P.C.; Lau, S.K.; Wong, B.H.; Fan, R.Y.; Wong, A.Y.; Zhang, A.J.; Wu, Y.; Choi, G.K.; Li, K.S.; Hui, J.; et al. Feline morbillivirus, a previously undescribed paramyxovirus associated with tubulointerstitial nephritis in domestic cats. Proc. Natl. Acad. Sci. USA 2012, 109, 5435–5440. [CrossRef] [PubMed]
32. Brown, D.D.; Collins, F.M.; Duprex, W.P.; Baron, M.D.; Barrett, T.; Rima, B.K. ‘Rescue’ of mini-genomic constructs and viruses by combinations of morbillivirus N, P and L proteins. J. Gen. Virol. 2005, 86 Pt 4, 1077–1081. [CrossRef] [PubMed]
33. Saikia, P.; Shaila, M.S. Identification of functional domains of phosphoproteins of two morbilliviruses using chimeric proteins. Virus Genes 2008, 37, 1–8. [CrossRef] [PubMed]
34. Spehner, D.; Kirn, A.; Drillien, R. Assembly of nucleocapsidlike structures in animal cells infected with a vaccinia virus recombinant encoding the measles virus nucleoprotein. J. Virol. 1991, 65, 6296–6300. [PubMed]
35. Mitra-Kaushik, S.; Nayak, R.; Shaila, M.S. Identification of a cytotoxic T-cell epitope on the recombinant nucleocapsid proteins of Rinderpest and Peste des petits ruminants viruses presented as assembled nucleocapsids. Virology 2001, 279, 210–220. [CrossRef] [PubMed]
36. Karlin, D.; Ferron, F.; Canard, B.; Longhi, S. Structural disorder and modular organization in Paramyxovirinae N and P. J. Gen. Virol. 2003, 84 Pt 12, 3239–3252. [CrossRef] [PubMed]
37. Bhella, D.; Ralph, A.; Murphy, L.B.; Yeo, R.P. Significant differences in nucleocapsid morphology within the Paramyxoviridae. J. Gen. Virol. 2002, 83 Pt 8, 1831–1839. [CrossRef] [PubMed]
38. Bhella, D.; Ralph, A.; Yeo, R.P. Conformational flexibility in recombinant measles virus nucleocapsids visualised by cryo-negative stain electron microscopy and real-space helical reconstruction. J. Mol. Biol. 2004, 340, 319–331. [CrossRef] [PubMed]
39. Schoehn, G.; Mavrakis, M.; Albertini, A.; Wade, R.; Hoenger, A.; Ruigrok, R.W. The 12 A structure of trypsin-treated measles virus N-RNA. J. Mol. Biol. 2004, 339, 301–312. [CrossRef] [PubMed]
40. Liljeroos, L.; Huiskonen, J.T.; Ora, A.; Susi, P.; Butcher, S.J. Electron cryotomography of measles virus reveals how matrix protein coats the ribonucleocapsid within intact virions. Proc. Natl. Acad. Sci. USA 2011, 108, 18085–18090. [CrossRef] [PubMed]
41. Gutsche, I.; Desfosses, A.; Effantin, G.; Ling, W.L.; Haupt, M.; Ruigrok, R.W.; Sachse, C.; Schoehn, G. Structural virology. Near-atomic cryo-EM structure of the helical measles virus nucleocapsid. Science 2015, 348, 704–707. [CrossRef] [PubMed]
42. Guryanov, S.G.; Liljeroos, L.; Kasaragod, P.; Kajander, T.; Butcher, S.J. Crystal Structure of the Measles Virus Nucleoprotein Core in Complex with an N-Terminal Region of Phosphoprotein. J. Virol. 2015, 90, 2849–2857. [CrossRef] [PubMed]
43. Jensen, M.R.; Communie, G.; Ribeiro, E.A., Jr.; Martinez, N.; Desfosses, A.; Salmon, L.; Mollica, L.; Gabel, F.; Jamin, M.; Longhi, S.; et al. Intrinsic disorder in measles virus nucleocapsids. Proc. Natl. Acad. Sci. USA 2011, 108, 9839–9844. [CrossRef] [PubMed]
44. Curran, J.; Homann, H.; Buchholz, C.; Rochat, S.; Neubert, W.; Kolakofsky, D. The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation. J. Virol. 1993, 67, 4358–4364. [PubMed]
45. Zhang, X.; Glendening, C.; Linke, H.; Parks, C.L.; Brooks, C.; Udem, S.A.; Oglesbee, M. Identification and characterization of a regulatory domain on the carboxyl terminus of the measles virus nucleocapsid protein. J. Virol. 2002, 76, 8737–8746. [CrossRef] [PubMed]
46. Wang, Y.; Chu, X.; Longhi, S.; Roche, P.; Han, W.; Wang, E.; Wang, J. Multiscaled exploration of coupled folding and binding of an intrinsically disordered molecular recognition element in measles virus nucleoprotein. Proc. Natl. Acad. Sci. USA 2013, 110, E3743–E3752. [CrossRef] [PubMed]
47. Han, M.; Xu, J.; Ren, Y.; Li, J. Simulation of coupled folding and binding of an intrinsically disordered protein in explicit solvent with metadynamics. J. Mol. Graph. Model. 2016, 68, 114–127. [CrossRef] [PubMed]
48. Kingston, R.L.; Hamel, D.J.; Gay, L.S.; Dahlquist, F.W.; Matthews, B.W. Structural basis for the attachment of a paramyxoviral polymerase to its template. Proc. Natl. Acad. Sci. USA 2004, 101, 8301–8306. [CrossRef] [PubMed]
49. Krumm, S.A.; Takeda, M.; Plemper, R.K. The measles virus nucleocapsid protein tail domain is dispensable for viral polymerase recruitment and activity. J. Biol. Chem. 2013, 288, 29943–29953. [CrossRef] [PubMed]
50. Hagiwara, K.; Sato, H.; Inoue, Y.; Watanabe, A.; Yoneda, M.; Ikeda, F.; Fujita, K.; Fukuda, H.; Takamura, C.; Kozuka-Hata, H.; et al. Phosphorylation of measles virus nucleoprotein upregulates the transcriptional activity of minigenomic RNA. Proteomics 2008, 8, 1871–1879. [CrossRef] [PubMed]
51. Zhang, X.; Bourhis, J.M.; Longhi, S.; Carsillo, T.; Buccellato, M.; Morin, B.; Canard, B.; Oglesbee, M. Hsp72 recognizes a P binding motif in the measles virus N protein C-terminus. Virology 2005, 337, 162–174. [CrossRef] [PubMed]
52. Couturier, M.; Buccellato, M.; Costanzo, S.; Bourhis, J.M.; Shu, Y.; Nicaise, M.; Desmadril, M.; Flaudrops, C.; Longhi, S.; Oglesbee, M. High affinity binding between Hsp70 and the C-terminal domain of the measles virus nucleoprotein requires an Hsp40 co-chaperone. J. Mol. Recognit. 2010, 23, 301–315. [CrossRef] [PubMed]
53. Iwasaki, M.; Takeda, M.; Shirogane, Y.; Nakatsu, Y.; Nakamura, T.; Yanagi, Y. The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J. Virol. 2009, 83, 10374–10383. [CrossRef] [PubMed]
54. Ray, G.; Schmitt, P.T.; Schmitt, A.P. C-Terminal DxD-Containing Sequences within Paramyxovirus Nucleocapsid Proteins Determine Matrix Protein Compatibility and Can Direct Foreign Proteins into Budding Particles. J. Virol. 2016, 90, 3650–3660. [CrossRef] [PubMed]
55. Curran, J.; Marq, J.B.; Kolakofsky, D. An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. J. Virol. 1995, 69, 849–855. [PubMed]
56. Communie, G.; Crepin, T.; Maurin, D.; Jensen, M.R.; Blackledge, M.; Ruigrok, R.W. Structure of the tetramerization domain of measles virus phosphoprotein. J. Virol. 2013, 87, 7166–7169. [CrossRef] [PubMed]
57. Shaji, D.; Shaila, M.S. Domains of Rinderpest virus phosphoprotein involved in interaction with itself and the nucleocapsid protein. Virology 1999, 258, 415–424. [CrossRef] [PubMed]
58. Rahaman, A.; Srinivasan, N.; Shamala, N.; Shaila, M.S. Phosphoprotein of the rinderpest virus forms a tetramer through a coiled coil region important for biological function. A structural insight. J. Biol. Chem. 2004, 279, 23606–23614. [CrossRef] [PubMed]
59. Raha, T.; Kaushik, R.; Shaila, M.S. Phosphoprotein P of Rinderpest virus binds to plus sense leader RNA: Regulation by phosphorylation. Virus Res. 2004, 104, 191–200. [CrossRef] [PubMed]
60. Saikia, P.; Gopinath, M.; Shaila, M.S. Phosphorylation status of the phosphoprotein P of rinderpest virus modulates transcription and replication of the genome. Arch. Virol. 2008, 153, 615–626. [CrossRef] [PubMed]
61. Sugai, A.; Sato, H.; Yoneda, M.; Kai, C. Phosphorylation of measles virus phosphoprotein at S86 and/or S151 downregulates viral transcriptional activity. FEBS Lett. 2012, 586, 3900–3907. [CrossRef] [PubMed]
62. Horikami, S.M.; Smallwood, S.; Bankamp, B.; Moyer, S.A. An amino-proximal domain of the L protein binds to the P protein in the measles virus RNA polymerase complex. Virology 1994, 205, 540–545. [CrossRef] [PubMed]
63. Connor, J.H.; McKenzie, M.O.; Parks, G.D.; Lyles, D.S. Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses. Virology 2007, 362, 109–119. [CrossRef] [PubMed]
64. Bloyet, L.M.; Welsch, J.; Enchery, F.; Mathieu, C.; de Breyne, S.; Horvat, B.; Grigorov, B.; Gerlier, D. Requirement of HSP90 chaperoning in addition to phosphoprotein for folding but not for supporting enzymatic activities of measles and Nipah virus L polymerases. J. Virol. 2016, 90, 6642–6656. [CrossRef] [PubMed]
65. Karlin, D.; Belshaw, R. Detecting remote sequence homology in disordered proteins: Discovery of conserved motifs in the N-termini of Mononegavirales phosphoproteins. PLoS ONE 2012, 7, e31719. [CrossRef] [PubMed]
66. Johansson, K.; Bourhis, J.M.; Campanacci, V.; Cambillau, C.; Canard, B.; Longhi, S. Crystal structure of the measles virus phosphoprotein domain responsible for the induced folding of the C-terminal domain of the nucleoprotein. J. Biol. Chem. 2003, 278, 44567–44573. [CrossRef] [PubMed]
67. Chen, M.; Cortay, J.C.; Gerlier, D. Measles virus protein interactions in yeast: New findings and caveats. Virus Res. 2003, 98, 123–129. [CrossRef] [PubMed]
68. Chattopadhyay, A.; Shaila, M.S. Rinderpest virus RNA polymerase subunits: Mapping of mutual interacting domains on the large protein L and phosphoprotein p. Virus Genes 2004, 28, 169–178. [CrossRef] [PubMed]
69. Nishio, M.; Tsurudome, M.; Ito, M.; Watanabe, N.; Kawano, M.; Komada, H.; Ito, Y. Human parainfluenza virus type 2 phosphoprotein: Mapping of monoclonal antibody epitopes and location of the multimerization domain. J. Gen. Virol. 1997, 78 Pt 6, 1303–1308. [CrossRef] [PubMed]
70. Choudhary, S.K.; Malur, A.G.; Huo, Y.; De, B.P.; Banerjee, A.K. Characterization of the oligomerization domain of the phosphoprotein of human parainfluenza virus type 3. Virology 2002, 302, 373–382. [CrossRef] [PubMed]
71. Smallwood, S.; Ryan, K.W.; Moyer, S.A. Deletion analysis defines a carboxyl-proximal region of Sendai virus P protein that binds to the polymerase L protein. Virology 1994, 202, 154–163. [CrossRef] [PubMed]
72. Emerson, S.U.; Yu, Y. Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus. J. Virol. 1975, 15, 1348–1356. [PubMed]
73. Hamaguchi, M.; Yoshida, T.; Nishikawa, K.; Naruse, H.; Nagai, Y. Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology 1983, 128, 105–117. [CrossRef]
74. Gupta, A.K.; Mathur, M.; Banerjee, A.K. Unique capping activity of the recombinant RNA polymerase (L) of vesicular stomatitis virus: Association of cellular capping enzyme with the L protein. Biochem. Biophys. Res. Commun. 2002, 293, 264–268. [CrossRef]
75. Ogino, T.; Kobayashi, M.; Iwama, M.; Mizumoto, K. Sendai virus RNA-dependent RNA polymerase L protein catalyzes cap methylation of virus-specific mRNA. J. Biol. Chem. 2005, 280, 4429–4435. [CrossRef] [PubMed]
76. Chattopadhyay, A.; Raha, T.; Shaila, M.S. Effect of single amino acid mutations in the conserved GDNQ motif of L protein of Rinderpest virus on RNA synthesis in vitro and in vivo. Virus Res. 2004, 99, 139–145. [CrossRef] [PubMed]
77. Muthuchelvan, D.; Sanyal, A.; Singh, R.P.; Hemadri, D.; Sen, A.; Sreenivasa, B.P.; Singh, R.K.; Bandyopadhyay, S.K. Comparative sequence analysis of the large polymerase protein (L) gene of peste-des-petits ruminants (PPR) vaccine virus of Indian origin. Arch. Virol. 2005, 150, 2467–2481. [CrossRef] [PubMed]
78. McIlhatton, M.A.; Curran, M.D.; Rima, B.K. Nucleotide sequence analysis of the large (L) genes of phocine distemper virus and canine distemper virus (corrected sequence). J. Gen. Virol. 1997, 78 Pt 3, 571–576. [CrossRef] [PubMed]
79. Duprex, W.P.; Collins, F.M.; Rima, B.K. Modulating the function of the measles virus RNA-dependent RNA polymerase by insertion of green fluorescent protein into the open reading frame. J. Virol. 2002, 76, 7322–7328. [CrossRef] [PubMed]
80. Brown, D.D.; Rima, B.K.; Allen, I.V.; Baron, M.D.; Banyard, A.C.; Barrett, T.; Duprex, W.P. Rational attenuation of a morbillivirus by modulating the activity of the RNA-dependent RNA polymerase. J. Virol. 2005, 79, 14330–14338. [CrossRef] [PubMed]
81. Ruedas, J.B.; Perrault, J. Insertion of enhanced green fluorescent protein in a hinge region of vesicular stomatitis virus L polymerase protein creates a temperature-sensitive virus that displays no virion-associated polymerase activity in vitro. J. Virol. 2009, 83, 12241–12252. [CrossRef] [PubMed]
82. Rahmeh, A.A.; Schenk, A.D.; Danek, E.I.; Kranzusch, P.J.; Liang, B.; Walz, T.; Whelan, S.P. Molecular architecture of the vesicular stomatitis virus RNA polymerase. Proc. Natl. Acad. Sci. USA 2010, 107, 20075–20080. [CrossRef] [PubMed]
83. Poch, O.; Blumberg, B.M.; Bougueleret, L.; Tordo, N. Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: Theoretical assignment of functional domains. J. Gen. Virol. 1990, 71 Pt 5, 1153–1162. [CrossRef] [PubMed]
84. Sidhu, M.S.; Menonna, J.P.; Cook, S.D.; Dowling, P.C.; Udem, S.A. Canine distemper virus L gene: Sequence and comparison with related viruses. Virology 1993, 193, 50–65. [CrossRef] [PubMed]
85. Cevik, B.; Holmes, D.E.; Vrotsos, E.; Feller, J.A.; Smallwood, S.; Moyer, S.A. The phosphoprotein (P) and L binding sites reside in the N-terminus of the L subunit of the measles virus RNA polymerase. Virology 2004, 327, 297–306. [CrossRef] [PubMed]
86. Jablonski, S.A.; Luo, M.; Morrow, C.D. Enzymatic activity of poliovirus RNA polymerase mutants with single amino acid changes in the conserved YGDD amino acid motif. J. Virol. 1991, 65, 4565–4572. [PubMed]
87. Gopinath, M.; Shaila, M.S. RNA triphosphatase and guanylyl transferase activities are associated with the RNA polymerase protein L of rinderpest virus. J. Gen. Virol. 2009, 90 Pt 7, 1748–1756. [CrossRef] [PubMed]
88. Paesen, G.C.; Collet, A.; Sallamand, C.; Debart, F.; Vasseur, J.J.; Canard, B.; Decroly, E.; Grimes, J.M. X-ray structure and activities of an essential Mononegavirales L-protein domain. Nat. Commun. 2015, 6, 8749. [CrossRef] [PubMed]
89. Singh, P.K.; Ratnam, N.; Narayanarao, K.B.; Bugatha, H.; Karande, A.A.; Melkote Subbarao, S. A carboxy terminal domain of the L protein of rinderpest virus possesses RNA triphosphatase activity—The first enzyme in the viral mRNA capping pathway. Biochem. Biophys. Res. Commun. 2015, 464, 629–634. [CrossRef] [PubMed]
90. Singh, P.K.; Subbarao, S.M. The RNA triphosphatase domain of L protein of Rinderpest virus exhibits pyrophosphatase and tripolyphosphatase activities. Virus Genes 2016, 52, 743–747. [CrossRef] [PubMed]
91. Gopinath, M.; Shaila, M.S. Evidence for N(7) guanine methyl transferase activity encoded within the modular domain of RNA-dependent RNA polymerase L of a Morbillivirus. Virus Genes 2015, 51, 356–360. [CrossRef] [PubMed]
92. Ferron, F.; Longhi, S.; Henrissat, B.; Canard, B. Viral RNA-polymerases—A predicted 20-O-ribose methyltransferase domain shared by all Mononegavirales. Trends Biochem. Sci. 2002, 27, 222–224. [CrossRef]
93. Li, J.; Wang, J.T.; Whelan, S.P. A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc. Natl. Acad. Sci. USA 2006, 103, 8493–8498. [CrossRef] [PubMed]
94. Nishio, M.; Tsurudome, M.; Garcin, D.; Komada, H.; Ito, M.; Le Mercier, P.; Nosaka, T.; Kolakofsky, D. Human parainfluenza virus type 2 L protein regions required for interaction with other viral proteins and mRNA capping. J. Virol. 2011, 85, 725–732. [CrossRef] [PubMed]
95. Neubauer, J.; Ogino, M.; Green, T.J.; Ogino, T. Signature motifs of GDP polyribonucleotidyltransferase, a non-segmented negative strand RNA viral mRNA capping enzyme, domain in the L protein are required for covalent enzyme-pRNA intermediate formation. Nucleic Acids Res. 2016, 44, 330–341. [CrossRef] [PubMed]
96. Qiu, S.; Ogino, M.; Luo, M.; Ogino, T.; Green, T.J. Structure and Function of the N-Terminal Domain of the Vesicular Stomatitis Virus RNA Polymerase. J. Virol. 2016, 90, 715–724. [CrossRef] [PubMed]
97. Liang, B.; Li, Z.; Jenni, S.; Rahmeh, A.A.; Morin, B.M.; Grant, T.; Grigorieff, N.; Harrison, S.C.; Whelan, S.P. Structure of the L Protein of Vesicular Stomatitis Virus from Electron Cryomicroscopy. Cell 2015, 162, 314–327. [CrossRef] [PubMed]
98. Poch, O.; Sauvaget, I.; Delarue, M.; Tordo, N. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. Embo J. 1989, 8, 3867–3874. [PubMed]
99. Li, J.; Rahmeh, A.; Morelli, M.; Whelan, S.P. A conserved motif in region v of the large polymerase proteins of nonsegmented negative-sense RNA viruses that is essential for mRNA capping. J. Virol. 2008, 82, 775–784. [CrossRef] [PubMed]
100. Li, J.; Fontaine-Rodriguez, E.C.; Whelan, S.P. Amino acid residues within conserved domain VI of the vesicular stomatitis virus large polymerase protein essential for mRNA cap methyltransferase activity. J. Virol. 2005, 79, 13373–13384. [CrossRef] [PubMed]
101. Biasini, M.; Bienert, S.; Waterhouse, A.; Arnold, K.; Studer, G.; Schmidt, T.; Kiefer, F.; Cassarino, T.G.; Bertoni, M.; Bordoli, L.; et al. SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014, 42, W252–W258. [CrossRef] [PubMed]
102. Yoon, J.J.; Krumm, S.A.; Ndungu, J.M.; Hoffman, V.; Bankamp, B.; Rota, P.A.; Sun, A.; Snyder, J.P.; Plemper, R.K. Target analysis of the experimental measles therapeutic AS-136A. Antimicrob. Agents Chemother. 2009, 53, 3860–3870. [CrossRef] [PubMed]
103. Renner, M.; Bertinelli, M.; Leyrat, C.; Paesen, G.C.; Saraiva de Oliveira, L.F.; Huiskonen, J.T.; Grimes, J.M. Nucleocapsid assembly in pneumoviruses is regulated by conformational switching of the N protein. Elife 2016, 5, e12627. [CrossRef] [PubMed]
104. Leyrat, C.; Yabukarski, F.; Tarbouriech, N.; Ribeiro, E.A., Jr.; Jensen, M.R.; Blackledge, M.; Ruigrok, R.W.; Jamin, M. Structure of the vesicular stomatitis virus N(0)-P complex. PLoS Pathogens 2011, 7, e1002248. [CrossRef] [PubMed]
105. Kirchdoerfer, R.N.; Abelson, D.M.; Li, S.; Wood, M.R.; Saphire, E.O. Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35 Complex. Cell Rep. 2015, 12, 140–149. [CrossRef] [PubMed]
106. Alayyoubi, M.; Leser, G.P.; Kors, C.A.; Lamb, R.A. Structure of the paramyxovirus parainfluenza virus 5 nucleoprotein-RNA complex. Proc. Natl. Acad. Sci. USA 2015, 112, E1792–E1799. [CrossRef] [PubMed]
107. Yabukarski, F.; Lawrence, P.; Tarbouriech, N.; Bourhis, J.M.; Delaforge, E.; Jensen, M.R.; Ruigrok, R.W.; Blackledge, M.; Volchkov, V.; Jamin, M. Structure of Nipah virus unassembled nucleoprotein in complex with its viral chaperone. Nat. Struct. Mol. Biol. 2014, 21, 754–759. [CrossRef] [PubMed]
108. Sugai, A.; Sato, H.; Hagiwara, K.; Kozuka-Hata, H.; Oyama, M.; Yoneda, M.; Kai, C. Newly identified minor phosphorylation site threonine-279 of measles virus nucleoprotein is a prerequisite for nucleocapsid formation. J. Virol. 2014, 88, 1140–1149. [CrossRef] [PubMed]
109. Cox, R.; Pickar, A.; Qiu, S.; Tsao, J.; Rodenburg, C.; Dokland, T.; Elson, A.; He, B.; Luo, M. Structural studies on the authentic mumps virus nucleocapsid showing uncoiling by the phosphoprotein. Proc. Natl. Acad. Sci. USA 2014, 111, 15208–15213. [CrossRef] [PubMed]
110. Pelet, T.; Delenda, C.; Gubbay, O.; Garcin, D.; Kolakofsky, D. Partial characterization of a Sendai virus replication promoter and the rule of six. Virology 1996, 224, 405–414. [CrossRef] [PubMed]
111. Tapparel, C.; Maurice, D.; Roux, L. The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: A motif (GNNNNN)3 is essential for replication. J. Virol. 1998, 72, 3117–3128. [PubMed]
112. Mioulet, V.; Barrett, T.; Baron, M.D. Scanning mutagenesis identifies critical residues in the rinderpest virus genome promoter. J. Gen. Virol. 2001, 82 Pt 12, 2905–2911. [CrossRef] [PubMed]
113. Walpita, P. An internal element of the measles virus antigenome promoter modulates replication efficiency. Virus Res. 2004, 100, 199–211. [CrossRef] [PubMed]
114. Desfosses, A.; Goret, G.; Farias Estrozi, L.; Ruigrok, R.W.; Gutsche, I. Nucleoprotein-RNA orientation in the measles virus nucleocapsid by three-dimensional electron microscopy. J. Virol. 2011, 85, 1391–1395. [CrossRef] [PubMed]
115. Katayama, H.; Hori, M.; Sato, K.; Kajita, M.; Ozaki, H.; Karaki, H.; Ohashi, K.; Kai, C. Role of actin microfilaments in canine distemper virus replication in vero cells. J. Vet. Med. Sci. 2004, 66, 409–415. [CrossRef] [PubMed]
116. Krumm, S.A.; Ndungu, J.M.; Yoon, J.J.; Dochow, M.; Sun, A.; Natchus, M.; Snyder, J.P.; Plemper, R.K. Potent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerases. PLoS ONE 2011, 6, e20069. [CrossRef] [PubMed]
117. Rinderpest officially eradicated. Vet. Rec. 2011, 169, 3.
118. OIE declares rinderpest eradicated. Vet. Rec. 2011, 168, 573.
119. Cima, G. Rinderpest eradicated. International organizations declare “cattle plague” dead. J. Am. Vet. Med. Assoc. 2011, 239, 11–15. [PubMed]
120. Holzmann, H.; Hengel, H.; Tenbusch, M.; Doerr, H.W. Eradication of measles: Remaining challenges. Med. Microbiol. Immunol. 2016, 205, 201–208. [CrossRef] [PubMed]
121. Simons, E.; Ferrari, M.; Fricks, J.; Wannemuehler, K.; Anand, A.; Burton, A.; Strebel, P. Assessment of the 2010 global measles mortality reduction goal: Results from a model of surveillance data. Lancet 2012, 379, 2173–2178. [CrossRef]
122. Moss, W.J.; Griffin, D.E. Global measles elimination. Nat. Rev. Microbiol. 2006, 4, 900–908. [CrossRef] [PubMed]
123. Appel, M.J.; Shek, W.R.; Shesberadaran, H.; Norrby, E. Measles virus and inactivated canine distemper virus induce incomplete immunity to canine distemper. Arch. Virol. 1984, 82, 73–82. [CrossRef] [PubMed]
124. Bieringer, M.; Han, J.W.; Kendl, S.; Khosravi, M.; Plattet, P.; Schneider-Schaulies, J. Experimental adaptation of wild-type canine distemper virus (CDV) to the human entry receptor CD150. PLoS ONE 2013, 8, e57488. [CrossRef] [PubMed]
125. Hall, W.C.; Kovatch, R.M.; Herman, P.H.; Fox, J.G. Pathology of measles in rhesus monkeys. Vet. Pathol. 1971, 8, 307–319. [PubMed]
126. Auwaerter, P.G.; Rota, P.A.; Elkins, W.R.; Adams, R.J.; DeLozier, T.; Shi, Y.; Bellini, W.J.; Murphy, B.R.; Griffin, D.E. Measles virus infection in rhesus macaques: Altered immune responses and comparison of the virulence of six different virus strains. J. Infect. Dis. 1999, 180, 950–958. [CrossRef] [PubMed]
127. Number of measles cases. European Center for Disease Control. and Prevention [Online.] 2011.
128. Measles Outbreak—California, December 2014–February 2015. MMWR Morb. Mortal. Wkly. Rep. 2015, 64, 153–154.
129. Ganellin, C.R.; Jefferis, R.; Roberts, S.M. Introduction to Biological and Small Molecule Drug Research and Development: Theory and Case Studies; Academic Press: Oxford UK, 2013.
130. Hosoya, M.; Shigeta, S.; Mori, S.; Tomoda, A.; Shiraishi, S.; Miike, T.; Suzuki, H. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis. Antimicrob. Agents Chemother. 2001, 45, 943–945. [CrossRef] [PubMed]
131. Manns, M.P.; McHutchison, J.G.; Gordon, S.C.; Rustgi, V.K.; Shiffman, M.; Reindollar, R.; Goodman, Z.D.; Koury, K.; Ling, M.; Albrecht, J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001, 358, 958–965. [CrossRef]
132. Manns, M.P.; Wedemeyer, H.; Cornberg, M. Treating viral hepatitis C: Efficacy, side effects, and complications. Gut 2006, 55, 1350–1359. [CrossRef] [PubMed]
133. Ndungu, J.M.; Krumm, S.A.; Yan, D.; Arrendale, R.F.; Reddy, G.P.; Evers, T.; Howard, R.; Natchus, M.G.; Saindane, M.T.; Liotta, D.C.; et al. Non-nucleoside Inhibitors of the Measles Virus RNA-Dependent RNA Polymerase: Synthesis, Structure-Activity Relationships, and Pharmacokinetics. J. Med. Chem. 2012, 55, 4220–4230. [CrossRef] [PubMed]
134. Sun, A.; Yoon, J.J.; Yin, Y.; Prussia, A.; Yang, Y.; Min, J.; Plemper, R.K.; Snyder, J.P. Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex. J. Med. Chem. 2008, 51, 3731–3741. [CrossRef] [PubMed]
135. White, L.K.; Yoon, J.J.; Lee, J.K.; Sun, A.; Du, Y.; Fu, H.; Snyder, J.P.; Plemper, R.K. Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity. Antimicrob. Agents Chemother. 2007, 51, 2293–2303. [CrossRef] [PubMed]
136. Tiong-Yip, C.L.; Aschenbrenner, L.; Johnson, K.D.; McLaughlin, R.E.; Fan, J.; Challa, S.; Xiong, H.; Yu, Q. Characterization of a respiratory syncytial virus L protein inhibitor. Antimicrob. Agents Chemother. 2014, 58, 3867–3873. [CrossRef] [PubMed]
137. Noton, S.L.; Nagendra, K.; Dunn, E.F.; Mawhorter, M.E.; Yu, Q.; Fearns, R. Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter. J. Virol. 2015, 89, 7786–7798. [CrossRef] [PubMed]
138. Mason, S.W.; Lawetz, C.; Gaudette, Y.; Do, F.; Scouten, E.; Lagace, L.; Simoneau, B.; Liuzzi, M. Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor. Nucleic Acids Res. 2004, 32, 4758–4767. [CrossRef] [PubMed]
139. Liuzzi, M.; Mason, S.W.; Cartier, M.; Lawetz, C.; McCollum, R.S.; Dansereau, N.; Bolger, G.; Lapeyre, N.; Gaudette, Y.; Lagace, L.; et al. Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase. J. Virol. 2005, 79, 13105–13115. [CrossRef] [PubMed]
140. Lim, S.V.; Rahman, M.B.; Tejo, B.A. Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus. BMC Bioinform. 2011, 12 (Suppl. 13), S24. [CrossRef] [PubMed]
141. Chapman, J.; Abbott, E.; Alber, D.G.; Baxter, R.C.; Bithell, S.K.; Henderson, E.A.; Carter, M.C.; Chambers, P.; Chubb, A.; Cockerill, G.S.; et al. RSV604, a novel inhibitor of respiratory syncytial virus replication. Antimicrob. Agents Chemother. 2007, 51, 3346–3353. [CrossRef] [PubMed]
142. Ouizougun-Oubari, M.; Pereira, N.; Tarus, B.; Galloux, M.; Lassoued, S.; Fix, J.; Tortorici, M.A.; Hoos, S.; Baron, B.; England, P.; et al. A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus. J. Virol. 2015, 89, 11129–11143. [CrossRef] [PubMed]
143. Smith, M.C.; Gestwicki, J.E. Features of protein-protein interactions that translate into potent inhibitors: Topology, surface area and affinity. Expert Rev. Mol. Med. 2012, 14, e16. [CrossRef] [PubMed]